Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus

Código QR

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus

Jaquellyne Gurgel Penaforte-Saboia,1,2 Carlos Eduardo Barra Couri,3 Natasha Vasconcelos Albuquerque,1,4 Vanessa Lauanna Lima Silva,5 Natália Bitar da Cunha Olegario,1,2 Virgínia Oliveira Fernandes,1,2,4 Renan Magalhães Montenegro Junior1,2,4 1Clinical Research Unit,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gurgel Penaforte-Saboia J, Couri CEB, Vasconcelos Albuquerque N, Silva VLL, Bitar da Cunha Olegario N, Oliveira Fernandes V, Montenegro RM Junior
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	cd26 type 1 diabetes mellitus autoimmunity autoantibodies therapeutic targets prevention. Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/3a1e029995cf4b5490aa9da89ab191ed
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
por: Nehru Sai Suresh Chalichem, et al.
Publicado: (2021)

Anemia hemolítica autoinmune en Chile: un análisis retrospectivo de 43 pacientes
por: López-Vidal,Hernán, et al.
Publicado: (2019)

APPLICATION OF DIFFERENT LABORATORY METHODS FOR ANTINUCLEAR AUTOANTIBODIES INVESTIGATION IN PATIENTS WITH AUTOIMMUNE CONNECTIVE TISSUE DISEASES
por: I. A. Pashnina, et al.
Publicado: (2012)

Enfermedades autoinmunitarias asociadas a diabetes mellitus tipo 1A
por: Ferreira-Hermosillo,Aldo, et al.
Publicado: (2015)

Bullous pemphigoid receiving a novel long‐acting dipeptidyl‐peptidase‐4 (DPP‐4) inhibitor omarigliptin in a patient with type 2 diabetes: A case report
por: Hiroshi Kasamatsu, et al.
Publicado: (2021)

Autoimmunity highlights

IMMUNOLOGICAL AND GENETIC CHANGES AS PREDICTORS IN THE LOSS OF PREGNANCY IN THE FORMATION OF RETROCHORIAL HEMATOMA IN THE FIRST TRIMESTER
por: M. V. Utrobin, et al.
Publicado: (2018)

N-Methyl-d-aspartate (NMDA) receptor antibody in relation to autism spectrum disorder (ASD): presence and association with symptom profile
por: Heba Hamed Elshahawi, et al.
Publicado: (2021)

PATHOGENETIC ROLE OF ABZYME-TYPE AUTOANTIBODIES IN THE ORGAN-SPECIFIC AUTOIMMUNE PATHOLOGY
por: L. N. Luchverchyk, et al.
Publicado: (2014)

Characterization of the serological biomarkers associated with Sjögren’s syndrome in patients with recalcitrant dry eye disease
por: Matossian C, et al.
Publicado: (2016)

Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with Drug-Resistant Temporal Lobe Epilepsy of Unknown Etiology
por: Pablo Cabezudo-García, et al.
Publicado: (2021)

Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA
por: Sutkowska E, et al.
Publicado: (2021)

Comparison of Serum Levels of Soluble CD26 and CD30 in Patients with Brucellosis and Controls
por: AR Rafiei,, et al.
Publicado: (2009)

Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates
por: Alida Linda Patrizia Caforio, et al.
Publicado: (2021)

Autoimmunity

Influence of silicone mammoplasty on the immunoendocrine status of female recipients
por: V. G. Zolotykh, et al.
Publicado: (2020)

CLINICAL DIAGNOSTIC VALUE OF AUTOANTIBODIES IN THE DIAGNOSIS OF AUTOIMMUNE LIVER DISEASES
por: V. V. Bazarnyi, et al.
Publicado: (2015)

Profile of several autoantibodies, complement and vitamin D levels in Brazilian patients with Chikungunya infection
por: J. F. Carvalho, et al.
Publicado: (2021)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
por: Das SS, et al.
Publicado: (2014)

Importance of Autoimmune Responses in Progression of Retinal Degeneration Initiated by Gene Mutations
por: Grazyna Adamus
Publicado: (2021)

COMPARISON OF SERUM LEVELS OF CD26 AND CD30 IN CHRONIC RENAL FAILURE AND HEMODIALYTIC PATIENTS
por: AR Rafiei,, et al.
Publicado: (2008)

Journal of autoimmunity

Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
por: Taras S. Panevin, et al.
Publicado: (2020)

Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus
por: Olga Sergeevna Derevyanko, et al.
Publicado: (2014)

LEVELS OF NEUROSPECIFIC ENOLASE AND ENOLASE-SPECIFIC AUTOANTIBODIES IN BLOOD SERUM OF THE PATIENTS WITH AUTOIMMUNE THYROPATIES
por: N. N. Tsybikov, et al.
Publicado: (2014)

Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts
por: Emilie Normand, et al.
Publicado: (2017)

IgM AUTOANTIBODIES TO DNA IN BLOOD SERUM OF THE PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROME
por: D. G. Ishmukhametova, et al.
Publicado: (2014)

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
por: Ali Ataya, et al.
Publicado: (2021)

INCIDENCE OF AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AND CHRONIC HEPATITIS C
por: K. L. Raikhelson, et al.
Publicado: (2014)

Typical case of LADA
por: A A Krivko, et al.
Publicado: (2009)

EARLY DIAGNOSTICS OF AUTOINFLAMMATORY DISORDERS ASSOCIATED WITH POST-VIRAL CHRONIC FATIGUE SYNDROME AND COGNITIVE IMPAIRMENTS IN CHRONIC MIXED HERPES VIRAL INFECTIONS
por: I. V. Nesterova, et al.
Publicado: (2021)

Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases
por: Dina S Ahmad, et al.
Publicado: (2013)

Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease
por: Sabrina Ceeraz, et al.
Publicado: (2021)

Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality.
por: Margaret G Gall, et al.
Publicado: (2013)

AUTOANTIBODIES AND CYTOKINE PROFILE IN PATIENTS WITH GRAVES–BASEDOW DISEASE AND THEIR DYNAMICS DURING THIONAMIDE THERAPY
por: E. V. Markelova, et al.
Publicado: (2014)

Manifestaciones clínicas y anticuerpos asociados y específicos de miositis en 15 pacientes chilenos con dermatomiositis: serie clínica en un centro universitario
por: Maraví T.,Zósimo, et al.
Publicado: (2020)

Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
por: Lin YH, et al.
Publicado: (2019)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Yi-Chen Li, et al.
Publicado: (2021)

The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity
por: Aleksander Sergeevich Ametov, et al.
Publicado: (2015)

Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates
por: Shitao Zhang, et al.
Publicado: (2021)